| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Alcobra Ltd. (ADHD) | Aegis Capital | $17.25 | n.a | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Platinum Energy Solutions (FRAC) | Morgan Stanley/ J.P. Morgan | 14.00 | $9.00 | $11.00 | $140.00 | 1-Star |
| New Terms | ||||||
| Bright Horizons Family Solutions (BFAM) | Goldman, Sachs/ J.P. Morgan/ Barclays | 10.10 | $19.00 | $21.00 | $202.00 | 2-Stars |
| KaloBios Pharmaceuticals (KBIO) | Leerink Swann | 3.85 | $12.00 | $14.00 | $50.05 | 1-Star |
| Taminco Global Chemical (tba) | Citigroup | $250.00 | 1-Star | |||
| TRI Pointe Homes (TPH) | Citigroup/ Deutsche Bank Securities/ FBR | 11.70 | $14.00 | $16.00 | $175.50 | 2-Stars |
| Zoetis (ZTS) | J.P. Morgan/ BofA Merrill Lynch/ Morgan Stanley | 86.10 | $22.00 | $25.00 | $2,023.35 | 3-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Jan. 14, 2013 | Manager(s) | Offered | Raised | Price | 1/18/13 | Change |
| Norwegian Cruise Line Holdings (NCLH) | UBS Investment Bank/ Barclays/ Citigroup/ Deutsche Bank Securities/ Goldman, Sachs/ J.P. Morgan | 23.50 | $446.50 | $19.00 | $24.79 | 30.47% |
| CyrusOne (CONE) | Morgan Stanley/ BofA Merrill Lynch | 16.50 | $313.50 | $19.00 | $21.20 | 11.58% |
| CVR Refining, LP (CVRR) | Credit Suisse/ Citigroup | 24.00 | $600.00 | $25.00 | $24.80 | -0.80% |
| USA Compression Partners, LP (USAC) | Barclays Capital/ Goldman, Sachs/ J.P. Morgan/ Wells Fargo Securities | 11.00 | $198.00 | $18.00 | $17.40 | -3.33% |
| SunCoke Energy Partners, L.P. (SXCP) | Barclays/ BofA Merrill Lynch/ Citigroup/ Credit Suisse/ J.P. Morgan | 13.50 | $256.50 | $19.00 | $18.25 | -3.95% |
